问题 › 我们靠不断折扣赢得交易 › 专业服务
常规折扣通常是证明问题和激励问题,几乎从来不是费率问题。 对专业服务公司来说,问题出现在特定位置。关键数字是可计费利用率和实现率,而本行业的特殊之处在于,合伙人薪酬制度理性地让人<em>不</em>去销售公司最高毛利的产品。这个问题的通用版本与你实际面对的版本,前期动作不同。
常规折扣通常是证明问题和激励问题,几乎从来不是费率问题。 对专业服务公司来说,问题出现在特定位置。关键数字是可计费利用率和实现率,而本行业的特殊之处在于,合伙人薪酬制度理性地让人不去销售公司最高毛利的产品。这个问题的通用版本与你实际面对的版本,前期动作不同。
当折扣成为常态,有效费率已重置为折扣水平,公布费率只是摆设。这带来的成本不止于单次项目毛利:它向市场传递了公司实际实现的价格,而且很难在不损害合伙人杠杆和人均收入的情况下逆转。
原因一致。交付价值未以客户愿意付费的方式证明,费率便成为唯一可谈的变量。或者合伙人薪酬按利用率和收入而非项目毛利计奖,这时折扣就是理性行为。或者任何需要保护自身实现率的合伙人都能决定费率。
诊断看分布。如果实现率在季度或年末大幅下降,而利用率持平,或不同合伙人在同类工作上实现率差异很大,原因就是激励和授权,而非公布费率。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 实现率在考核期末下降,利用率却保持不变
✓ 类似范围和客户的项目,合伙人之间的项目毛利差异很大
✓ 合伙人要求费率让步,而不是收紧范围或加强价值证明
通常会让情况更糟的做法。 下调标准费率以匹配近期实现率,这会重置锚点,两季度内又会出现对新费率的相同折扣。
It is for you if you run or finance a professional services firm and discounts spike at period end. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家专业服务公司. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Aldergate Partners, a sample company profile used for testing rather than a customer — $88M revenue, 310 people.
Excerpt from a real Percision run · Competitive Positioning · sample company profile
The move. Re-align partner economics so the $85K diagnostic becomes the highest-compensated path to the $410K implementation.
The leak it closes. Partner-level incentive leakage that currently diverts 25% of diagnostic-eligible opportunities back to T&M work
The assumption it rests on. 15-of-22 partners approve compensation redesign within 60 days — the engine put the probability at 0.7.
| Investment required | $700K total over 36 months — $200K annual incentive pool × 3 years + $100K legal and change-management cost |
| Expected return | 3.4× cash-on-cash over 36 months (NPV $2.4M / $700K investment) on $58.0M current revenue base |
| Revenue, year 1 | +$1.2M incremental diagnostic and implementation revenue (15 additional diagnostics × $85K + 12 conversions × $410K) |
| Revenue, year 2 | +$2.4M cumulative incremental revenue |
| Revenue, year 3 | +$3.7M cumulative incremental revenue |
| Exit criteria | Terminate this move and revert to legacy compensation if (a) fewer than 12-of-22 partners approve redesign by Day 60, or (b) any top-3 account issues an RFP within 90 days of announcement, or (c) diagnostic-to-implementation conversion falls below 10-of-19 by December 31, 2026. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to 定价与收入优化, one of 29 engagements the platform runs. For 专业服务公司 it works through billable utilisation, realisation, revenue per partner and engagement gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
限制折扣权限,按毛利而非收入支付奖金。折扣是对收入指标加无限定价权的理性回应。
不是——如果是有意用作交换条件,比如换取付款期、规模或案例引用。但若只是谈判结束时的条件反射,就是无谓让出的毛利。
续约时提前通知并说明理由,接受部分客户流失。否则市场最终会发现永久的两套价格。
Materially, yes. Partner compensation rationally pays people not to sell the highest-margin product in the firm — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are billable utilisation, realisation, revenue per partner, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on billable utilisation and realisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית